DMCPA

DMCPA
Clinical data
Other names25D-CPA; 2,5-Dimethoxy-4-methylphenylcyclopropylamine; 4-Methyl-2,5-dimethoxyphenylcyclopropylamine
Routes of
administration
Oral
Drug classSerotonin 5-HT2A receptor agonist; Serotonin receptor modulator; Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Pharmacokinetic data
Onset of action1 hour
Duration of action4–8 hours
Identifiers
  • 2-(2,5-dimethoxy-4-methylphenyl)cyclopropan-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H17NO2
Molar mass207.273 g·mol−1
3D model (JSmol)
  • O(c1c(cc(OC)c(c1)C2CC2N)C)C
  • InChI=1S/C12H17NO2/c1-7-4-12(15-3)9(6-11(7)14-2)8-5-10(8)13/h4,6,8,10H,5,13H2,1-3H3 checkY
  • Key:HYVPPECPQRBJEQ-UHFFFAOYSA-N checkY
  (verify)

DMCPA, also known as 2,5-dimethoxy-4-methylphenylcyclopropylamine, is a psychedelic drug of the phenethylamine, amphetamine, and phenylcyclopropylamine families related to DOM. It is a derivative of tranylcypromine and is the cyclized phenethylamine analogue of DOM in which the α and β positions have been connected with a carbon atom to form a cyclopropyl group.

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists DMCPA's dose as 15 to 20 mg orally and its duration as 4 to 8 hours. Its onset is 1 hour. The effects of DMCPA have been reported to include psychedelic visuals such as visual movement, fantasy, eroticism, feeling decoupled from one's experience and environment, feeling like the aura before a seizure, lightheadedness, feeling loss of control and uncomfortable, muscle tremors, mild anorexia, bizarre and colorful dreams during subsequent sleep, and no next-day hangover. It was said to have too much in the way of physical side effects and hints of physical toxicity at the highest assessed dose.

Interactions

Pharmacology

Pharmacodynamics

The comprehensive receptor interactions of DMCPA have been studied. In contrast to tranylcypromine, it shows very weak activity as a monoamine oxidase inhibitor (MAOI).

Chemistry

Synthesis

The chemical synthesis of DMCPA has been described.

Analogues

Analogues of DMCPA include 3,4,5-trimethoxytranylcypromine (TMT), tranylcypromine, and DOM, among others.

History

DMCPA was first described in the scientific literature by at least 1974.

Society and culture

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.

See also